The FDA has approved a new daily oral pill designed to lower cholesterol levels significantly beyond what statins — the current standard of care — can achieve. The approval is backed by clinical trial results demonstrating superior LDL reduction compared to existing treatments. Statins are among the most widely prescribed drugs in the world, making this a notable shift in cardiovascular treatment options. A pill-based alternative that outperforms statins could reshape prescribing guidelines and expand access to effective cholesterol management for millions of patients.